In this issue of Clinics in Liver Disease, guest editor Mitchell L Shiffman brings considerable expertise to the topic of Challenging Issues in the Management of Chronic Hepatitis B Virus.
Key Features
- Provides in-depth, clinical reviews on the latest updates in Challenging Issues in the Management of Chronic Hepatitis B Virus, providing actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Author Information
Edited by Mitchell L Shiffman, MD, Director, Bon Secours Liver Institute of Richmond, Bon Secours Liver Instiutute of Hampton, St Mary’s Hospital, Richmond, VA, USA
The Changing Demographics of Hepatitis B Virus InfectionInterpretation of HBV SerologiesTreatment and Prevention of Acute Hepatitis B VirusTreatment of Chronic Hepatitis B Virus with Oral Anti-Viral TherapyControversies in Treating Chronic HBV: The Role of PEG-interferon-alfaControversies in Treating Chronic Hepatitis B virus: The Role of Hepatitis B Virus DNA and Surface Antigen TiterControversies in the Management of Hepatitis B: Hepatocellular CarcinomaControversies in Treating Chronic Hepatitis B Virus Infection: Discordant Serologic ResultsChronic Hepatitis B Virus in Patients with Chronic Hepatitis C VirusNew Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus InfectionUse of Hepatitis B Virus–Positive Organs in Organ TransplantationHepatitis B and Health Care WorkersNovel Therapies That May Cure Chronic Hepatitis B Virus